Is endothelial nitric oxide availability and vascular repair capacity lower at age 64?

Age-related vascular changes provide a biologically credible explanation for why endothelial dysfunction and atherosclerotic susceptibility become more likely by the mid-60s, although the magnitude varies substantially among individuals.

Clinical and vascular evidence

• Compared with younger adults, healthy older adults generally have lower flow-mediated dilation, an endothelium-dependent measure to which nitric oxide (NO) bioavailability materially contributes. Thus, at age 64, lower endothelial NO availability is likely, though not directly quantifiable from age alone.
• Small studies comparing adults with mean ages of approximately 61 versus 25 years found reduced progenitor-cell survival, migration, and proliferation in the older group, alongside poorer flow-mediated dilation. Evidence favors impaired repair-cell function more consistently than a uniform reduction in circulating cell numbers.
• In the Bruneck Study, endothelial progenitor-cell counts declined with age and were inversely associated with carotid intima–media thickness; however, colony-forming capacity was not associated with this marker, illustrating that “vascular repair capacity” is not captured by a single validated clinical assay.

Mechanistic relevance

• Reduced NO production and oxidative NO inactivation impair endothelium-dependent vasodilation. Superoxide can consume NO to form peroxynitrite, while oxidative stress and reduced availability of the eNOS cofactor BH₄ can further compromise NO signaling.
• Loss of NO’s vasodilatory, anti-inflammatory, and antithrombotic actions favors vasoconstriction, leukocyte and platelet adhesion, and smooth-muscle proliferation—processes central to atherogenesis and plaque progression.
• Reduced repair capacity plausibly limits recovery after endothelial injury, but its independent clinical contribution is less firmly established than the NO pathway.

Clinical implications

• Menopausal/estrogen-related biology, physical activity, cardiometabolic health, medications, and hormone therapy can substantially modify these age-related patterns.
• Brachial flow-mediated dilation is not recommended for routine risk assessment in asymptomatic adults; when prevention decisions are uncertain, selective coronary-artery calcium assessment is supported for risk reclassification.

Bottom line

• At 64, lower endothelial NO availability and reduced vascular-repair function are likely relative to younger adulthood, increasing susceptibility to endothelial dysfunction and mechanistically to atherosclerosis, but age alone cannot determine an individual’s vascular risk.